title: [Endothelial microparticles (EMP) in physiology and pathology].
abstract: Endothelial microparticles (EMP) are released from endothelial cells (ECs) in the process of activation and/or apoptosis. They harbor adhesive molecules, enzymes, receptors and cytoplasmic structures and express a wide range of various constitutive antigens, typical for ECs, at their surface. Under physiological conditions the concentration of EMP in the blood is clinically insignificant. However, it was reported that under pathological conditions EMP concentration in the blood might slightly increase and contribute to blood coagulation, angiogenesis and inflammation. It has been shown that EMP directly and indirectly contribute to the activation of blood coagulation. Endothelial microparticles directly participate in blood coagulation through their surface tissue factor (TF) - a major initiator of blood coagulation. Furthermore, EMP exhibit procoagulant potential via expression of negatively charged phospholipids at their surface, which may promote assembly of coagulation enzymes (TF/VII, tenases and prothrombinase complexes), leading to thrombus formation. In addition, they provide a binding surface for coagulation factors: IXa, VIII, Va and IIa. Moreover, it is possible that EMP transfer TF from TF-bearing EMP to activated platelets and monocytes by binding them through adhesion molecules. Also, EMP express von Willebrand factor, which may facilitate platelet aggregation. Apart from their procoagulant properties, it was demonstrated that EMP may express adhesive molecules and metalloproteinases (MMP-2, MMP-9) at their surface and release growth factors, which may contribute to angiogenesis. Additionally, surface presence of C3 and C4 - components of the classical pathway - suggests pro-inflammatory properties of these structures. This article contains a summary of available data on the biology and pathophysiology of endothelial microparticles and their potential role in blood coagulation, angiogenesis and inflammation.
authors.affiliation: Klinika Onkologii, Uniwersytet Medyczny w Białymstoku; Białostockie Centrum Onkologii.
authors.forename: Ewa
authors.initials: E
authors.lastname: Sierko
authors.affiliation: Klinika Onkologii, Uniwersytet Medyczny w Białymstoku.
authors.forename: Monika
authors.initials: M
authors.lastname: Sokół
authors.affiliation: Klinika Onkologii, Uniwersytet Medyczny w Białymstoku; Białostockie Centrum Onkologii.
authors.forename: Marek Z
authors.initials: MZ
authors.lastname: Wojtukiewicz
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D001777:Blood Coagulation / Q000502:physiology*; D055252:Cell-Derived Microparticles / Q000502:physiology*; D042783:Endothelial Cells / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000502:physiology*